Zdrowie i gospodarka · 16/11/2004
FDA Clears DYCLONE Topical Solutions for Approval
The FDA has determined that DYCLONE 0.5% and 1.0% Topical Solutions were not withdrawn from sale due to safety or effectiveness concerns, paving the way for approval of abbreviated new drug applications for these products.